🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To determine what side effects and what clinical effect, if any, the admini...
Status
Completed
Location
Research site
Start Date
2002-11
Trial ID
NCT00048555
Treatments Being Tested
This is a Phase III, multicenter, global, clinical study of an investigatio...
Status
Terminated
Location
Multiple Locations
Start Date
2006-09
Trial ID
NCT00363636
Treatments Being Tested
RATIONALE: Monoclonal antibodies, such as rituximab and galiximab, can bloc...
Status
Completed
Location
Lombardi Comprehensive Cancer Center at Georgetown University Medical Center
Start Date
2005-06
Trial ID
NCT00117975
The purpose of the study is to evaluate the mechanism(s) of action of galix...
Status
Terminated
Location
Research Site
Start Date
2008-08
Trial ID
NCT00651443
Treatments Being Tested
The purpose of this study is to determine whether anti-CD80 monoclonal anti...
Status
Completed
Location
Research Site
Start Date
2002-01
Trial ID
NCT00575068
Treatments Being Tested
RATIONALE: Monoclonal antibodies, such as galiximab, can block cancer growt...
Status
Completed
Location
Tunnell Cancer Center at Beebe Medical Center
Start Date
2008-06
Trial ID
NCT00516217
Treatments Being Tested
This is a Phase III, multicenter, global, open-label, single-arm, retreatme...
Status
Terminated
Location
Multiple Locations
Start Date
2007-11
Trial ID
NCT00384150
Treatments Being Tested